Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd Smith

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Nature Biotechnology|November 10, 2012
Genome interpretation and assembly-recent progress and next stepsShawn Baker, Anika Joecker, George Church, et al.
Paediatric Anaesthesia|January 29, 2005
Nesiritide during extracorporeal membrane oxygenationTodd Smith, David A Rosen, Pierantonio Russo, et al.
Methods in Enzymology|January 13, 2005
Transgene-induced RNA interference as a tool for plant functional genomicsKaren McGinnis, Vicki Chandler, Karen Cone, et al.
Neuropharmacology|September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measuresCarina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
Assay and Drug Development Technologies|April 20, 2004
Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptorsJayne Chin, Alan D Adams, Aileen Bouffard, et al.
Analytical Biochemistry|June 27, 2006
A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activationShane Marine, Elize Zamiara, S Todd Smith, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology|November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Assay and Drug Development Technologies|June 29, 2010
A 1,536-well ultra-high-throughput siRNA screen to identify regulators of the Wnt/beta-catenin pathwayNamjin Chung, Shane Marine, Emily A Smith, et al.
Pilot and Feasibility Studies|October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Nature Biotechnology|November 10, 2012
Genome interpretation and assembly-recent progress and next stepsShawn Baker, Anika Joecker, George Church, et al.
Paediatric Anaesthesia|January 29, 2005
Nesiritide during extracorporeal membrane oxygenationTodd Smith, David A Rosen, Pierantonio Russo, et al.
Methods in Enzymology|January 13, 2005
Transgene-induced RNA interference as a tool for plant functional genomicsKaren McGinnis, Vicki Chandler, Karen Cone, et al.
Neuropharmacology|September 1, 2025
Qualitative Content Analysis of Expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measuresCarina Joy Donegan, Dimitri Daldegan-Bueno, Tehseen Noorani, et al.
Assay and Drug Development Technologies|April 20, 2004
Miniaturization of cell-based beta-lactamase-dependent FRET assays to ultra-high throughput formats to identify agonists of human liver X receptorsJayne Chin, Alan D Adams, Aileen Bouffard, et al.
Analytical Biochemistry|June 27, 2006
A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activationShane Marine, Elize Zamiara, S Todd Smith, et al.
Biological Psychiatry|March 30, 2023
Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled TrialRobin J Murphy, Rachael Sumner, William Evans, et al.
Neuropharmacology|November 7, 2025
LSD microdosing in major depressive disorder: results from an open-label trialDimitri Daldegan-Bueno, Carina Joy Donegan, Rachael Sumner, et al.
Assay and Drug Development Technologies|June 29, 2010
A 1,536-well ultra-high-throughput siRNA screen to identify regulators of the Wnt/beta-catenin pathwayNamjin Chung, Shane Marine, Emily A Smith, et al.
Pilot and Feasibility Studies|October 5, 2023
An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)Carina Joy Donegan, Dimitri Daldegan-Bueno, Rachael Sumner, et al.
Pageof 7